Blog articles12 January 2021 Webinar Recap: eConsent. Why now? Why Castor? COVID-19 changed the conversation around enrollment and recruitment for clinical trials. Learn how eConsent is helping researchers do more despite restrictions. Learn more
Webinar18 December 2020 Advanced Features of Castor EDC for Study Admins During this webinar you will learn tips and tricks on how to implement some of the advanced features in Castor EDC. Learn more
Webinar18 December 2020 Dos and Don’ts for Building Your Study in Castor In this webinar, we discuss best and worst practices while building a study, when to use specific forms, working with fields effectively and tips to create a user-friendly study. Learn more
Blog articles17 December 2020 Castor Launches Scalable Decentralized Trial Platform After 383% Commercial Growth Hoboken, New Jersey: December 17, 2020: Castor, a leading provider of clinical trial technology, today announced the launch… Learn more
Blog articles14 December 2020 Top Four eConsent Questions from Clinical Researchers In September 2020, Castor CEO Derk Arts, MD, Ph.D., led a webinar on electronic informed consent (eConsent) challenges… Learn more
Success Stories9 December 2020 Castor Helps Power the WHO Solidarity Trial Against COVID-19 Learn how Castor was instrumental in meeting the World Health Organization's need for a rapidly-deployable, scalable EDC solution with advanced functionality. Learn more
Blog articles8 December 2020 Castor Expands Advisory Board to Support US Growth of Decentralized Clinical Trial Platform Industry veterans from leading life sciences companies including Johnson & Johnson, Biogen, and Medtronic, will support the Company’s… Learn more
White papers & guides30 November 2020 eBook: The Decentralized Clinical Trial Playbook This playbook is a tool for sponsors and CROs who want to leverage DCT technology to support remote interactions in their clinical studies. Learn more
Blog articles19 November 2020 UKCA Mark: The Impact of Brexit on Medical Devices and 7 Steps to Prepare In the wake of Brexit, medical device companies secure a UKCA mark as proof of conformity to place their device on the UK market. Learn what this means for your organization and how to prepare. Learn more
Blog articles12 November 2020 Decentralized Trial Tech Strategy In Three Steps Though technologies that support decentralized clinical trials (DCT) have been readily available for years, meaningful industry adoption has… Learn more
